Although patients with prostate cancer endorse multiple sources of information, they report greatest satisfaction with information from the treating physician about patient outcomes, according to ...
A retrospective analysis of intramural NCI prostate cancer trials: Progress made and insights gleaned. Background: To date, docetaxel (D) is the only chemotherapy agent that has provided a survival ...
Bayer HealthCare provided support for this research. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial ...
In a study published in Urologic Oncology, researchers found long-term survival of young men who undergo radical prostatectomy for high-risk prostate cancer is highly satisfactory. Paolo Dell’Oglio, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback